Company intelligence / Profile preview
Centre for Probe Development and Commercialization
Hamilton, Ontario, Canadacpdc.ca ↗
- Ownership
- Private
- Employees
- ~51
- Development stage
- Phase 3
01
Overview
CPDC has supported or conducted over 60 clinical trials—including Phase 3—across Canada, North America, and Europe. It has provided more than 65,000 clinical doses to patients in Canada. The company specializes in the development of diagnostic and therapeutic radiopharmaceuticals targeting cancer and neurological conditions.
- Therapeutic areas
- OncologyNeurologyOther
- Modalities
- RadiopharmaceuticalSmall molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
University Health NetworkOttawa Heart InstituteCancer Care Ontarionumerous academic/pharma collaborations
Beyond the preview
Go deeper on Centre for Probe Development and Commercialization.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Centre for Probe Development and Commercialization.